Paper - WANFANG MED ONLINE

You Position: Home > Paper

中国老年慢性阻塞性肺疾病临床诊治实践指南

( views:743, downloads:8698 )

Author:: No author available

Journal Title:: Chinese Journal of Tuberculosis and Respiratory Diseases

Issue:: 2

DOI:: 10.3760/cma.j.issn.1001-0939.2020.02.007

Key Word:: No keyword available

Abstract：慢性阻塞性肺疾病(慢阻肺)是一种常见的、可以预防和治疗的疾病,以持续性呼吸道症状和气流受限为特征,通常由于明显暴露于有害颗粒或气体导致气道和(或)肺泡异常.老年人是慢阻肺的高发人群,对慢阻肺的知晓率低,诊断不足问题严重.老年慢阻肺患者临床症状缺乏特异性,常合并存在多种疾病,同时老年人具有相应的病理生理特点,因此老年人群慢阻肺的诊治面临挑战.为了提高广大医生对老年慢阻肺的重视程度,指导临床医生充分考虑老年慢阻肺患者的特点进行个体化诊治和管理,中国老年医学学会呼吸病学分会慢阻肺学组在遵循国内外循证医学证据的基础上,经全体学组委员多次现场工作会议讨论,并广泛征求国内相关领域专家的意见后,经过多次修改,最终定稿.

Reference

[1]国家卫生计生委合理用药专家委员会,中国药师协会.心力衰竭合理用药指南（第2版）[J].2019,(7).
[2]朱琳媛.基层医院使用BIPAP治疗AECOPD合并Ⅱ型呼衰的疗效观察[J].2016,(17).
[3]《中国老年骨质疏松症诊疗指南》(2018)工作组,中国老年学和老年医学学会骨质疏松分会,马远征,等.中国老年骨质疏松症诊疗指南（2018）[J].2018,(12).
[4]胡湘麟.肺癌合并慢性阻塞性肺疾病（COPD）患者围手术期优化管理的研究进展[J].2019,(2).
[5]包晨,杨冬.COPD合并肺癌的发病机制与治疗进展[J].2016,(8).
[6]高阳,程远大,董硕,等.围术期应用氨溴索对胸腔镜下肺叶切除术后肺癌患者的作用[J].2014,(8).
[7]樊静,王宁,方利文,等.2014年中国40岁及以上人群慢性阻塞性肺疾病知识知晓率及其影响因素[J].2018,(5).
[8]刘菁,刘学东.慢性阻塞性肺疾病合并侵袭性肺曲霉病35例文献分析[J].2013,(4).
[9]刘晓立,高维.老年慢性阻塞性肺病急性加重期患者呼吸道致病菌分布及耐药性分析[J].2016,(10).
[10]Guiping Yu,Guoqiang Chen,Bin Huang,etc.Effect of early enteral nutrition on postoperative nutritional status and immune function in elderly patients with esophageal cancer or cardiac cancer[J].2013,(3).
[11]中华医学会呼吸病学分会呼吸危重症医学学组,中国医师协会呼吸医师分会危重症医学工作委员会.成人经鼻高流量湿化氧疗临床规范应用专家共识[J].2019,(2).
[12]成人支气管扩张症诊治专家共识编写组.成人支气管扩张症诊治专家共识[J].2012,(7).
[13]刘朝,肖丹,王辰.戒烟是慢性阻塞性肺疾病防治的最有效措施[J].2017,(12).
[14]汪群智,盛美玲,楼亚波.慢性阻塞性肺疾病合并侵袭性肺曲霉病的危险因素及临床特征分析[J].2016,(6).
[15]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].2018,(9).
[16]Tow Keang, Lim,Cynthia B, Chee,Patsy, Chow,etc.Ministry of Health Clinical Practice Guidelines: Chronic Obstructive Pulmonary Disease.[J].2018,59(2).
[17]Holland, Anne E.,Mahal, Ajay,Hill, Catherine J.,etc.Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial[J].2017,72(1).
[18]Yong Bum, Park,Chin Kook, Rhee,Hyoung Kyu, Yoon,etc.Revised (2018) COPD Clinical Practice Guideline of the Korean Academy of Tuberculosis and Respiratory Disease: A Summary.[J].2018,(Spec ).
[19]Klaus F,Rabe,John R,Hurst,Samy,Suissa.Cardiovascular disease and COPD: dangerous liaisons?[J].2018,27(149).
[20]Iwata T,Yoshida S,Chiyo M,etc.Trends of bacterial colonisation and the risk of postoperative pneumonia in lung cancer patients with chronic obstructive pulmonary disease.[J].2010,37(4).
[21]Lundell, Sara,Holmner, Asa,Rehn, Boerje,etc.Telehealthcare in COPD: A systematic review and meta-analysis on physical outcomes and dyspnea[J].2015,109(1).
[22]Kumar Narayanan,Kyndaron Reinier,Audrey Uy-Evanado,etc.Chronic Obstructive Pulmonary Disease and Risk of Sudden Cardiac Death[J].2015,1(5).
[23]F. Rodrigues,M. Grafino,I. Faria,etc.Surgical risk evaluation of lung cancer in COPD patients - A cohort observational study[J].2016,(5).
[24]汪复, 张婴元主编.实用抗感染治疗学[M].2012.
[25]Freeman, Richard K.,Ascioti, Anthony J.,Dake, Megan,etc.The Effects of a Multidisciplinary Care Conference on the Quality and Cost of Care for Lung Cancer Patients[J].2015,100(5).
[26]Diane Podsiadlo,Sandra Richardson.The Timed “Up&Go”: A Test of Basic Functional Mobility for Frail Elderly Persons[J].1991,39(2).
[27]Jianmin, Jin,Shuling, Li,Wenling, Yu,etc.Emphysema and bronchiectasis in COPD patients with previous pulmonary tuberculosis: computed tomography features and clinical implications.[J].2018,13(Spec ).
[28]Paglino G,Pedone C,Battaglia S,etc.Chronic renal failure: a neglected comorbidity of COPD.[J].2010,137(4).
[29]C-H, Tseng.Metformin and risk of chronic obstructive pulmonary disease in diabetes patients.[J].2018,(Spec ).
[30]Cazzola,M.,Matera,M.G.,Calzetta,L.,etc.Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional study[J].2012,106(2).
[31]Seyed-Mohammad-Yousof,Mostafavi-Pour-Manshadi,Nafiseh,Naderi,Miriam,Barrecheguren,etc.Investigating Fractional Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease (COPD) and Asthma-COPD Overlap (ACO): A Scoping Review.[J].2018.
[32]MacDonald, Martin I.,Shafuddin, Eskandarain,King, Paul T.,etc.Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease[J].2016,4(2).
[33]Xiaochun,Xiao,Hedong,Han,Cheng,Wu,etc.Prevalence of Atrial Fibrillation in Hospital Encounters With End-Stage COPD on Home Oxygen: National Trends in the United States.[J].2019,155(5).
[34]Lauderdale,D.S.,Naureckas,E.T.,Lee,T.A.,etc.The validity of international classification of diseases, ninth revision, clinical modification: Diagnosis codes for identifying patients hospitalized for COPD exacerbations[J].2012,141(1).
[35]Lea Schirnhofer,Bernd Lamprecht,William M. Vollmer,etc.COPD Prevalence in Salzburg, Austria: Results From the Burden of Obstructive Lung Disease (BOLD) Study[J].2007,131(1).
[36]Liu, Yang,Narayanan, Kumar,Zhang, Zhiwei,etc.Chronic obstructive pulmonary disease and risk of sudden cardiac death[J].2016,214.
[37]Kewu Huang,Ting Yang,Jianying Xu,etc.Prevalence, risk factors, and management of asthma in China: a national cross-sectional study[J].2019,394(10196).
[38]Portegies, Marileen L. P.,Lahousse, Lies,Joos, Guy F.,etc.Chronic Obstructive Pulmonary Disease and the Risk of Stroke The Rotterdam Study[J].2016,193(3).
[39]Molyneaux,P.L.,Mallia,P.,Cox,M.J.,etc.Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease[J].2013,188(10).
[40].Occurrence of Anxiety and Depression among Stable COPD Patients and its Impact on Functional Capability.[J].2017,11(2).
[41]Ou, Yong-er,Lin, Zhi-min,Wu, Wei-liang,etc.Efficacy of non-invasive ventilation as a rescue therapy for relieving dyspnea in patients with stable severe COPD[J].2016,121.
[42]K. M.Mulpeter,J. B.Walsh,M.O'Connor,etc.Ocular hazards of nebulized bronchodilators.[J].1992,68(796).
[43]Gerstein,H.,Lindberg,B.,Carlsson,L.-G.,etc.Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids[J].2012,106(11).
[44]Courtney Crim,Mark T. Dransfield,Jean Bourbeau,etc.Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD[J].2015,12(1).
[45]Zhang, Can-You,Zhao, Fei,Xia, Yin-Yin,etc.Prevalence and risk factors of active pulmonary tuberculosis among elderly people in China: a population based cross-sectional study.[J].2019,8(1).
[46]Puchades, Ramon,Gonzalez, Begona,Contreras, Mar,etc.Cardiovascular profile in critically ill elderlymedical patients: Prevalence, mortality and length of stay[J].2015,26(1).
[47]Papi, Alberto,Vestbo, Jorgen,Fabbri, Leonardo,etc.Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial[J].2018,391(10125).
[48]Qing, Chen,Chi, Wu,Yang, Gao,etc.A clinical study on the role of psychosomatic therapy in evaluation and treatment of patients with chronic obstructive pulmonary disease complicated with anxiety-depression disorder.[J].2015,8.
[49]Lacasse, Yves,Tan, Ai-Yui M.,Maltais, Francois,etc.Home Oxygen in Chronic Obstructive Pulmonary Disease[J].2018,197(10).
[50]Mercado, Nicolas,Ito, Kazuhiro,Barnes, Peter J..Accelerated ageing of the lung in COPD: new concepts[J].2015,70(5).
[51]Mona Bafadhel,Stefan Peterson,Miguel A De Blas,etc.Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials[J].2018,6(2).
[52]Xiao-Min, Lu,Ji-Ping, Zhu,Xian-Mei, Zhou.The effect of benzodiazepines on insomnia in patients with chronic obstructive pulmonary disease: a meta-analysis of treatment efficacy and safety.[J].2016.
[53]Tomasic, Nikica,Kelava, Tomislav,Krpan, Miroslav,etc.Continuous remote monitoring of COPD patients-justification and explanation of the requirements and a survey of the available technologies[J].2018,56(4).
[54]de-Torres, Juan P.,Wilson, David O.,Sanchez-Salcedo, Pablo,etc.Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease Development and Validation of the COPD Lung Cancer Screening Score[J].2015,191(3).
[55]Eva A M, van Eerd,Regina M, van der Meer,Onno C P, van Schayck,etc.Smoking cessation for people with chronic obstructive pulmonary disease.[J].2016.
[56]Vestbo, Jorgen,Papi, Alberto,Corradi, Massimo,etc.Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial[J].2017,389(10082).
[57]Qingxia, Du,Jianmin, Jin,Xiaofang, Liu,etc.[J].2016,11(3).
[58]A-M, Selzler,J, Wald,M, Sedeno,etc.Telehealth pulmonary rehabilitation: A review of the literature and an example of a nationwide initiative to improve the accessibility of pulmonary rehabilitation.[J].2018,15(1).
[59]Martijn A. Spruit,Sally j. Singh,Chris Garvey,etc.An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation[J].2013,188(8).
[60]Laurie L, Carr,Sean, Jacobson,David A, Lynch,etc.Features of Chronic Obstructive Pulmonary Disease as Predictors of Lung Cancer.[J].2018,(Spec ).
[61]Takashi Nojiri,Masayoshi Inoue,Kazuhiro Yamamoto,etc.Inhaled tiotropium to prevent postoperative cardiopulmonary complications in patients with newly diagnosed chronic obstructive pulmonary disease requiring lung cancer surgery.[J].2014,44(2).
[62]Chen, Wang,Jianying, Xu,Lan, Yang,etc.Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.[J].2018,391(10131).
[63]Gallagher SP,Lajoie Y.Predicting falls within the elderly community: comparison of postural sway, reaction time, the Berg balance scale and the Activities-specific Balance Confidence (ABC) scale for comparing fallers and non-fallers.[J].2004,38(1).
[64]Yu Ree, Kim,In Cheol, Hwang,Yong Joo, Lee,etc.Stroke risk among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.[J].2018,73(Spec ).
[65]Bestall JC,Paul EA,Garrod R,etc.Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.[J].1999,54(7).
[66]Youfeng, Zhu,Haiyan, Yin,Rui, Zhang,etc.Gastric versus postpyloric enteral nutrition in elderly patients (age ≥?75?years) on mechanical ventilation: a single-center randomized trial.[J].2018,22(1).
[67]SAMY SUISSA,BRENDA HEMMELGARN,LUCIE BLAIS,etc.Bronchodilators and Acute Cardiac Death[J].1996,154(6 Pt.1).
[68]Gary T,Ferguson,Klaus F,Rabe,Fernando J,Martinez,etc.Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled tr[J].2018,6(10).
[69]Herer P,Lavie P,Lavie L.Mortality risk factors in sleep apnoea: a matched case-control study.[J].2007,16(1).
[70]Brian J,Lipworth,David J,Collier,Yasuhiro,Gon,etc.Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA.[J].2018,13.
[71]Pavord, Ian D.,Lettis, Sally,Anzueto, Antonio,etc.Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis[J].2016,4(9).
[72]Steven Pascoe,Nicholas Locantore,Mark T Dransfield,etc.Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials[J].2015,3(6).
[73]Lopez AD,Held LS,Buist S,etc.Chronic obstructive pulmonary disease: current burden and future projections.[J].2006,27(2).
[74]Jing Pan,Lin Xu,Shao Xi Cai,etc.The association of pulmonary function with carotid atherosclerosis in older Chinese: Guangzhou Biobank Cohort Study-CVD Subcohort[J].2015,243(2).
[75]Boyaci, N.,Kara, Iskender,Yildirim, F.,etc.The impact of frailty on noninvasive mechanical ventilation in elderly medical intensive care unit patients[J].2018,30(4).
[76]Cecilia Mouronte-Roibás,Virginia Leiro-Fernández,Alberto Fernández-Villar,etc.COPD, emphysema and the onset of lung cancer. A systematic review[J].2016,(2).
[77]Solanes, Ingrid,Alfageme, Inmaculada,de-Torres, Juan P.,etc.Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort[J].2016,149(1).
[78]Maigeng Zhou*,Haidong Wang*,Xinying Zeng,etc.Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J].2019,394(10204).
[79]Ding, Zhen,Li, Xiu,Lu, Youjin,etc.A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease[J].2016,121.
[80]Claudio Sorino,Nicola Scichilone,Claudio Pedone,etc.When kidneys and lungs suffer together[J].2019,32(5).
[81]Xuejiao Sun,Zhiyi He,Jianquan Zhang,etc.Compare the efficacy of inhaled budesonide and systemic methylprednisolone on systemic inflammation of AECOPD[J].2015,31.
[82]Lipson, David A.,Barnhart, Frank,Brealey, Noushin,etc.Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD[J].2018,378(18).
[83]Fan Vincent S..Sex, Depression, and Risk of Hospitalization and Mortality in Chronic Obstructive Pulmonary Disease[J].2007.
[84]Crim, Courtney,Calverley, Peter M. A.,Anderson, Julie A.,etc.Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial[J].2017,131.
[85]Romme,E.A.,Smeenk,F.W.,Rutten,E.P.,etc.Osteoporosis in chronic obstructive pulmonary disease[J].2013,7(4).
[86]Stoller JK,Panos RJ,Krachman S,etc.Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial.[J].2010,138(1).
[87]Austin, Victoria,Crack, Peter J.,Bozinovski, Steven,etc.COPD and stroke: are systemic inflammation and oxidative stress the missing links?[J].2016,(13).
[88]Baird, Chelsea,Lovell, Janaka,Johnson, Marilyn,etc.The impact of cognitive impairment on self-management in chronic obstructive pulmonary disease: A systematic review[J].2017,129.
[89]Yohannes, Abebaw M.,Muellerova, Hana,Hanania, Nicola A.,etc.Long-term Course of Depression Trajectories in Patients With COPD A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort[J].2016,149(4).
[90]Wedzicha, Jadwiga A.,Miravitlles, Marc,Hurst, John R.,etc.Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline[J].2017,49(3).
[91]Luis Javier, Nannini,Phillippa, Poole,Stephen J, Milan,etc.Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.[J].2013.
[92]Peter F Collins,Marinos Elia,Rebecca J Stratton.Nutritional support and functional capacity in chronic obstructive pulmonary disease: A systematic review and meta-analysis.[J].2013,18(4).
[93]Isabel Correia, Maria,Hegazi, Refaat A.,Diaz-Pizarro Graf, Jose Ignacio,etc.Addressing Disease-Related Malnutrition in Healthcare: A Latin American Perspective[J].2016,40(3).
[94]Leuppi,J.D.,Schuetz,P.,Bingisser,R.,etc.Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: The REDUCE randomized clinical trial[J].2013,309(21).
[95]Claire, Delsuc,Aurélie, Cottereau,Emilie, Frealle,etc.Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study.[J].2015,19.
[96]Lavorini, Federico,Mannini, Claudia,Chellini, Elisa,etc.Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices[J].2016,33(7).
[97]Marin,J.M.,Soriano,J.B.,Carrizo,S.J.,etc.Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: The overlap syndrome[J].2010,182(3).
[98]Allinson, James P.,Hardy, Rebecca,Donaldson, Gavin C.,etc.Combined Impact of Smoking and Early-Life Exposures on Adult Lung Function Trajectories[J].2017,196(8).
[99]Bo, Ding,Marco, DiBonaventura,Niklas, Karlsson,etc.Asthma-chronic obstructive pulmonary disease overlap syndrome in the urban Chinese population: prevalence and disease burden using the 2010, 2012, and 2013 China National Health and Wellness Surveys.[J].2016.
[100]Bonten, M. J. M.,Huijts, S. M.,Bolkenbaas, M.,etc.Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults[J].2015,372(12).
[101]Lipworth, Brian,Wedzicha, Jadwiga,Devereux, Graham,etc.Beta-blockers in COPD: time for reappraisal[J].2016,48(3).
[102]Hawkins NM,Huang Z,Pieper KS.Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).[J].2009,11(3).
[103]Detterbeck, Frank C.,Bach, Peter B.,Mazzone, Peter J.,etc.Screening for Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].2013,143(5 Suppl.).
[104]Zamboni, Mauro,Zanardi, Erika,Rossi, Andrea,etc.Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?[J].2015,32(9).
[105]Meriam, Denguezli,Hager, Daldoul,Imed, Harrabi,etc.[J].2016,11(3).
[106]Julia Ae, Walters,Joanne Ngie Qing, Tang,Phillippa, Poole,etc.Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.[J].2017,1(Spec ).
[107]D L, Ross,R K, Schultz.Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products.[J].1996,9(2).
[108]W T, McNicholas,P M A, Calverley,A, Lee,etc.Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD.[J].2004,23(6).
[109]N B, Pride.Ageing and changes in lung mechanics.[J].2005,26(4).
[110]Jones, Sarah E.,Maddocks, Matthew,Kon, Samantha S. C.,etc.Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation[J].2015,70(3).
[111]Tse-Hsuan, Su,Shang-Hung, Chang,Pei-Chun, Chen,etc.Temporal Trends in Treatment and Outcomes of Acute Myocardial Infarction in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Observational Study.[J].2017,6(3).
[112]L U, Tiong,R, Davies,P G, Gibson,etc.Lung volume reduction surgery for diffuse emphysema.[J].2006,(4).
[113]P H, Brekke,T, Omland,S H, Holmedal,etc.Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation.[J].2008,31(3).
[114]Janice M, Leung,Don D, Sin.Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets.[J].2017,358(Spec ).
[115]P W, Jones,G, Harding,P, Berry,etc.Development and first validation of the COPD Assessment Test.[J].2009,34(3).
[116]M, Decramer,W, Janssens.Mucoactive therapy in COPD.[J].2010,19(116).
[117]Antonelli M,Spadetta G,Navalesi P,etc.Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial.[J].2002,28(12).
[118]Yasuda H,Nakayama K,Sasaki T.A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients.[J].2009,57(8).
[119]Sherin Hassan Mohammed, Mehani.Comparative study of two different respiratory training protocols in elderly patients with chronic obstructive pulmonary disease.[J].2017,12(Spec ).
[120]W Darlene, Reid,Cristiane, Yamabayashi,Donna, Goodridge,etc.Exercise prescription for hospitalized people with chronic obstructive pulmonary disease and comorbidities: a synthesis of systematic reviews.[J].2012,7.
[121]Ivone M, Ferreira,Dina, Brooks,John, White,etc.Nutritional supplementation for stable chronic obstructive pulmonary disease.[J].2012,12.
[122]Sui, Zhu,Lan, Xia,Shicheng, Yu,etc.The burden and challenges of tuberculosis in China: findings from the Global Burden of Disease Study 2015.[J].2017,7(1).
[123]Dheeraj, Gupta,Ritesh, Agarwal,Ashutosh Nath, Aggarwal,etc.Guidelines for diagnosis and management of chronic obstructive pulmonary disease: joint recommendations of Indian Chest Society and National College of Chest Physicians (India).[J].2014,56 Spec No.
[124]Veronika, Williams,Jonathan, Price,Maxine, Hardinge,etc.Using a mobile health application to support self-management in COPD: a qualitative study.[J].2014,64(624).
[125]Cai B,Zhu Y,Ma Y,etc.Effect of Supplementing a High-Fat, Low-Carbohydrate Enteral Formula in COPD Patients.[J].2003,19(3).
[126]Vasileios, Andrianopoulos,Rainer, Gloeckl,Ioannis, Vogiatzis,etc.Cognitive impairment in COPD: should cognitive evaluation be part of respiratory assessment?[J].2017,13(1).
[127]Bernard, McCarthy,Dympna, Casey,Declan, Devane,etc.Pulmonary rehabilitation for chronic obstructive pulmonary disease.[J].2015,2.
[128]Yingying, Zheng,Yiyi, Zhou,Qiujia, Lai.Effects of Twenty-four Move Shadow Boxing Combined with psychosomatic relaxation on Depression and Anxiety in Patients with Type-2 Diabetes.[J].2015,27(2).
[129]Corry-Anke, Brandsma,Maaike, de Vries,Rita, Costa,etc.Lung ageing and COPD: is there a role for ageing in abnormal tissue repair?[J].2017,26(146).
[130]Bei, Mao,Hai-Wen, Lu,Man-Hui, Li,etc.The existence of bronchiectasis predicts worse prognosis in patients with COPD.[J].2015,5.
[131]Yingmeng, Ni,Guochao, Shi,Youchao, Yu,etc.Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis.[J].2015,10.
[132]Plant PK,Owen JL,Elliott MW.Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial.[J].2000,355(9219).
[133]Eberlein M,Eckhoff J,Schirren J,etc.Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.[J].2011,39(6).
[134]Valdivia G,Hallal PC,Victora CG,etc.Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study.[J].2005,366(9500).
[135]Siddiqui, Selman H.,Guasconi, Alessandro,Vestbo, Jorgen,etc.Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease[J].2015,192(4).
[136].Targeting occult heart failure in intensive care unit patients with acute chronic obstructive pulmonary disease exacerbation: Effect on outcome and quality of life[J].2014,29(2).
[137]Adama, Sana,Serge M A, Somda,Nicolas, Meda,etc.Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis.[J].2018,5(1).
[138]G E, Packe,R M, Cayton,N, Mashhoudi.Nebulised ipratropium bromide and salbutamol causing closed-angle glaucoma.[J].1984,2(8404).